How long should fraxiparine (nadroparin) be stopped before a cesarean section in a pregnant patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Fraxiparine Discontinuation Before Cesarean Section

Fraxiparine (nadroparin) should be discontinued at least 24 hours prior to a planned cesarean section to minimize bleeding risk and allow safe neuraxial anesthesia. 1

Evidence-Based Timing Recommendations

Standard Guideline Recommendation

  • The American College of Chest Physicians strongly recommends discontinuing LMWH at least 24 hours prior to induction of labor or cesarean section (Grade 1B). 1 This timing applies specifically to women receiving adjusted-dose LMWH therapy and is critical for safe placement of neuraxial anesthesia (epidural or spinal). 1

  • The American Society of Hematology 2018 guidelines reinforce this 24-hour minimum interval, emphasizing that this window allows adequate clearance of anticoagulant effect to reduce bleeding complications during surgery and permit safe epidural placement. 1

Supporting Clinical Data

  • Observational studies demonstrate that women who delivered within 24 hours of their last heparin injection had prolonged aPTT values at delivery, increasing bleeding risk. 2 In one series, 6 of 11 women (55%) receiving subcutaneous heparin delivered with prolonged aPTT when the interval was less than 24 hours. 2

  • A retrospective study of different nadroparin regimens showed that pre-operative administration of nadroparin 5700 IU significantly increased bleeding complications requiring either conservative treatment or re-laparotomy (19/574 women, 3.3%) compared to postoperative-only dosing (1/306 women, 0.3%; p=0.005). 3

Coordination with Anesthesia

  • The exact timing should be coordinated with the obstetrics and anesthesia teams, as intravenous heparin (if used) should be stopped at least 6 hours before delivery to allow safe epidural placement. 1 While this refers to UFH, the principle of coordinating with anesthesia applies equally to LMWH.

  • For women on therapeutic-dose LMWH, consultation with a high-risk obstetrician and obstetric anesthesiologist is specifically recommended regarding optimal timing of discontinuation in preparation for epidural anesthesia. 1

Practical Implementation Algorithm

For Planned Cesarean Section:

  1. Stop fraxiparine 24 hours before scheduled surgery time 1
  2. Verify adequate time interval with anesthesia team before neuraxial block placement 1
  3. Resume LMWH postoperatively when hemostasis is assured (typically 6-12 hours post-cesarean for prophylactic dosing, longer for therapeutic dosing) 3

For Spontaneous Labor:

  1. Instruct patient to stop fraxiparine immediately at onset of labor or membrane rupture 2
  2. Check aPTT if delivery occurs within 24 hours of last dose 2
  3. Consider protamine sulfate reversal if emergency cesarean is needed with recent LMWH administration 2

Critical Caveats

  • The 24-hour minimum is non-negotiable for planned procedures. Women delivering within 28 hours of their last heparin injection are at risk for prolonged anticoagulation at delivery. 2

  • Prophylactic-dose nadroparin (2850 IU) administered postoperatively only (not pre-operatively) significantly reduces bleeding complications compared to pre- and post-operative dosing. 3 This supports avoiding pre-operative LMWH administration when cesarean section is planned.

  • For women on therapeutic anticoagulation for acute VTE, the risk-benefit calculation differs, but the 24-hour discontinuation window before planned delivery remains standard. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thrombophylaxis and bleeding complications after cesarean section.

Acta obstetricia et gynecologica Scandinavica, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.